•  
  • 中华人民共和国国家卫生健康委员会 主管
  • 中国医学科学院 主办
杂志信息/Information
  • 刊名:癌症进展
  • Oncology Progress Journal
  • 主管:国家卫生健康委员会
  • 主办:中国医学科学院
  • 社长:张凌
  • 主编:赵平
  • 编辑部主任:穆红
  • 编辑部副主任:陈闻
  • 编辑出版:中国协和医科大学出版社
    《癌症进展》编辑部
    100730,北京东单三条9号
    电话:010-57528107
    E-mail:azjzzz@163.com
    http://www.aizhengjinzhan.com
  • 市场运营:惠生文化传媒(北京)有限公司
    李长松 沈杰
  • 印刷:北京联合互通彩色印刷有限公司
  • 国内统一连续出版物号:CN 11-4971/R
  • 国际标准连续出版物号ISSN 1672-1535
下载专区/Download
订阅电子期刊/Subscribe

提交您的邮箱地址,我们会定期将电子期刊 发送到您的邮箱

期刊检索/Journal Search
扫一扫,关注

过刊目录

2015 年第 2 期 第 13 卷

靶控麻醉对直肠癌根治术患者细胞免疫功能变化的影响研究

作者:

单位:

关键词:靶控麻醉直肠癌根治术细胞免疫功能

  • 摘要:
  • 【摘要】目的:研究靶控麻醉与直肠癌根治术患者细胞免疫功能变化关系;方法:选择2012年8月——2014年10月在我院行直肠癌根治术治疗的患者68例,分为靶控麻醉组(34例)与对照组(34例),靶控麻醉组行靶控麻醉,对照组行全身麻醉;结果:靶控麻醉组麻醉成功、术毕、术后24h等时点肿瘤坏死因子-α、血清白细胞介素-6水平均较麻醉前升高(p<0.05);两组患者麻醉成功、术毕等时点的肿瘤坏死因子-α、血清白细胞介素-6水平均较麻醉前升高(p<0.05)。靶控麻醉组麻醉成功、术毕等时点肿瘤坏死因子-α、血清白细胞介素-6水平均高于对照组(p<0.05)。靶控麻醉组麻醉成功、术毕、术后24h等时点的CD3、CD4、CD8以及CD4/CD8均显著低于对照组(p<0.05);结论:与全身麻醉相比较,靶控麻醉能够显著抑制的患者的细胞免疫功能。
  • Objective: To study the relationship between the target control anesthesia in radical operation of cell immune function of the patients with rectal cancer changes; methods: 68 patients in 2012 August -- 2014 October radical resection of rectal cancer treated in our hospital, were divided into target control anesthesia group (34 cases) and the control group (34 cases), Target control anesthesia group underwent target control anesthesia, the control group underwent general anesthesia.; results: Target control anesthesia anesthesia in the patients after successful, the end of operation, tumor necrosis factor - 24h point alpha, interleukin -6 in serum levels was significantly elevated compared with those before anesthesia (P < 0.05); control group of two groups of patients in the anesthesia and postoperative success at the tumor necrosis factor alpha, blood innocent interleukin -6 levels were significantly elevated compared with those before anesthesia (P < 0.05). Target control anesthesia group anesthesia success, postoperative time point such as tumor necrosis factor alpha, interleukin -6 in serum was significantly higher than those of the control group (P < 0.05). target control anesthesia group anesthesia success, after operation, postoperative 24h at CD3, CD4, CD8 and CD4/CD8 were significantly lower than those of the control group (P < 0.05); conclusion: Compared with general anesthesia, target control anesthesia can significantly inhibit the cellular immune function in patients.